by Devon M. Herrick
National Center for Policy Analysis
May 29, 2014
Patients benefit enormously from safe and effective drug therapies. Highly advanced specialty drugs and biological agents are increasingly used to treat rare diseases and disorders for which there were no treatments only a few years ago. Advanced drug therapies are very expensive, and often require special handling and extensive patient monitoring. Yet, many states have enacted regulations and ill-conceived public policies that force health plans to utilize drug providers who are unqualified to administer these exacting therapies. Not only do such policies boost patients’ costs, they also compromise safety and invite fraudulent providers who jeopardize the effectiveness of specialty drug therapies.

Heritage FoundationInsiderOnline is a product of The Heritage Foundation.
214 Massachusetts Avenue NE | Washington DC 20002-4999
ph 202.546.4400 | fax 202.546.8328
© 1995 - 2015 The Heritage Foundation